These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26500992)

  • 1. Telogen Effluvium: A Review.
    Malkud S
    J Clin Diagn Res; 2015 Sep; 9(9):WE01-3. PubMed ID: 26500992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telogen effluvium.
    Harrison S; Sinclair R
    Clin Exp Dermatol; 2002 Jul; 27(5):389-5. PubMed ID: 12190639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic telogen effluvium.
    Whiting DA
    Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized Telogen Effluvium Following Hair Transplantation.
    Loh SH; Lew BL; Sim WY
    Ann Dermatol; 2018 Apr; 30(2):214-217. PubMed ID: 29606820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric Surgery-Induced Telogen Effluvium (Bar SITE): Case Report and a Review of Hair Loss Following Weight Loss Surgery.
    Cohen-Kurzrock RA; Cohen PR
    Cureus; 2021 Apr; 13(4):e14617. PubMed ID: 34055500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women.
    Malkud S
    J Clin Diagn Res; 2015 Aug; 9(8):WC01-4. PubMed ID: 26436027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotin Deficiency in Telogen Effluvium: Fact or Fiction?
    Abdel Rahman SH; Mohammed Salem R; Hassan Sabry J
    J Clin Aesthet Dermatol; 2020 Mar; 13(3):37-40. PubMed ID: 32308796
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients.
    İbiş S; Aksoy Saraç G; Akdağ T
    Dermatol Pract Concept; 2022 Jul; 12(3):e2022151. PubMed ID: 36159144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic telogen effluvium: a study of 5 patients over 7 years.
    Sinclair R
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):12-6. PubMed ID: 15692504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
    Gilmore S; Sinclair R
    Australas J Dermatol; 2010 Aug; 51(3):163-7. PubMed ID: 20695853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.
    Savci U; Senel E; Oztekin A; Sungur M; Erel O; Neselioglu S
    An Bras Dermatol; 2020; 95(4):447-451. PubMed ID: 32482549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.